SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-24-000094
Filing Date
2024-01-18
Accepted
2024-01-18 16:18:32
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g07422imux_01182024.htm SC 13G 277032
2 JOINT FILING AGREEMENT ex991to13g07422imux_01182024.htm EX-99.1 8395
  Complete submission text file 0000921895-24-000094.txt   287209
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Subject) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88651 | Film No.: 24542064
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)